Medical News Today -- Celera Corporation (NASDAQ:CRA) announced the publication of a review article on the KIF6 gene variant as a predictor of risk of coronary heart disease (CHD) and reduction of CHD events from statin therapy.
Medical News Today -- Celera Corporation (NASDAQ:CRA) announced the publication of a review article on the KIF6 gene variant as a predictor of risk of coronary heart disease (CHD) and reduction of CHD events from statin therapy.